NEW YORK – Stella Diagnostics said on Wednesday that it has entered a collaborative research agreement with the Mayo Clinic to evaluate its test for predicting disease progression in Barrett's esophagus.
NEW YORK – Stella Diagnostics said on Wednesday that it has entered a collaborative research agreement with the Mayo Clinic to evaluate its test for predicting disease progression in Barrett's esophagus.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.